B2M and type 2 diabetes mellitus: The detection of B2M and CC16 with the C18 plate—MALDI-TOF MS approach could be an attractive and practical assay for rapid diagnosis of nephropathy in nondiabetic/diabetic patients and as a predictor of ERFD among T2D patients who had not manifested significant kidney disease at baseline.